466 related articles for article (PubMed ID: 12804417)
21. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
[TBL] [Abstract][Full Text] [Related]
22. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial.
Lassen AT; Hallas J; Schaffalitzky de Muckadell OB
Gut; 2004 Dec; 53(12):1758-63. PubMed ID: 15542510
[TBL] [Abstract][Full Text] [Related]
23. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial).
Delaney BC; Qume M; Moayyedi P; Logan RF; Ford AC; Elliott C; McNulty C; Wilson S; Hobbs FD
BMJ; 2008 Mar; 336(7645):651-4. PubMed ID: 18310262
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori eradication in patients on long-term H2 receptor antagonists. Economic and symptomatic benefits. A large prospective study in primary care.
Verma S; Giaffer MH
Helicobacter; 2002 Apr; 7(2):91-8. PubMed ID: 11966867
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.
Ford AC; Qume M; Moayyedi P; Arents NL; Lassen AT; Logan RF; McColl KE; Myres P; Delaney BC
Gastroenterology; 2005 Jun; 128(7):1838-44. PubMed ID: 15940619
[TBL] [Abstract][Full Text] [Related]
27. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2006 Jul; (3):CD002095. PubMed ID: 16855986
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the dyspeptic patient: a cost-utility study.
Ebell MH; Warbasse L; Brenner C
J Fam Pract; 1997 Jun; 44(6):545-55. PubMed ID: 9191627
[TBL] [Abstract][Full Text] [Related]
29. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
[TBL] [Abstract][Full Text] [Related]
30. Empirical treatment followed by a test-and-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting.
Laheij RJ; Hermsen JT; Jansen JB; Horrevorts AM; Rongen RJ; Van Rossum LG; Witteman E; de Koning RW
Fam Pract; 2004 Jun; 21(3):238-43. PubMed ID: 15128682
[TBL] [Abstract][Full Text] [Related]
31. Economic evaluation of a randomized trial comparing Helicobacter pylori test-and-treat and prompt endoscopy strategies for managing dyspepsia in a primary-care setting.
Klok RM; Arents NL; de Vries R; Thijs JC; Brouwers JR; Kleibeuker JH; Postma MJ
Clin Ther; 2005 Oct; 27(10):1647-57. PubMed ID: 16330302
[TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
[TBL] [Abstract][Full Text] [Related]
33. Dyspepsia and Helicobacter pylori.
Selgrad M; Kandulski A; Malfertheiner P
Dig Dis; 2008; 26(3):210-4. PubMed ID: 18463437
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological interventions for non-ulcer dyspepsia.
Moayyedi P; Soo S; Deeks J; Delaney B; Innes M; Forman D
Cochrane Database Syst Rev; 2003; (1):CD001960. PubMed ID: 12535421
[TBL] [Abstract][Full Text] [Related]
35. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease.
van Pinxteren B; Numans ME; Bonis PA; Lau J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002095. PubMed ID: 15495027
[TBL] [Abstract][Full Text] [Related]
36. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.
Moayyedi P; Soo S; Deeks J; Forman D; Mason J; Innes M; Delaney B
BMJ; 2000 Sep; 321(7262):659-64. PubMed ID: 10987767
[TBL] [Abstract][Full Text] [Related]
37. Guidelines for the management of dyspepsia.
Talley NJ; Vakil N;
Am J Gastroenterol; 2005 Oct; 100(10):2324-37. PubMed ID: 16181387
[TBL] [Abstract][Full Text] [Related]
38. The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia.
Moayyedi P; Zilles A; Clough M; Hemingbrough E; Chalmers DM; Axon AT
Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1245-50. PubMed ID: 10563534
[TBL] [Abstract][Full Text] [Related]
39. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
40. Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia.
Ford AC; Moayyedi P; Jarbol DE; Logan RF; Delaney BC
Aliment Pharmacol Ther; 2008 Sep; 28(5):534-44. PubMed ID: 18616641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
